Author

Shirish M. Gadgeel

Henry Ford HealthORCID 0000-0001-5240-3811Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:protein structure prediction· 1 Approach:statistical model· 1

Frequent Co-Authors

Benjamin MovsasiD· 1 shared Farzan SiddiquiiD· 1 shared Fawzi Abu RousiD· 1 shared Hassan Mohammed AbushukairiD· 1 shared Nallasivam PalanisamyiD· 1 shared Oudai Hassan· 1 shared Pin LiiD· 1 shared Rebecca Chacko· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Benjamin MovsasORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCancersPeer-reviewedSep 27, 2024

BUB1 inhibition sensitizes lung cancer cell lines to radiotherapy and chemoradiotherapy

Shivani Thoidingjam, Sushmitha Sriramulu, Oudai Hassan…·Shyam Nyati

This study shows BUB1 inhibition enhances the effectiveness of radiotherapy and chemoradiation in lung cancer cell lines.

14 citations

humanexperimental assay

𝕏 PostBluesky

GenomicsJTO Clinical and Research ReportsPeer-reviewedFeb 28, 2023

Brief Report: Prognostic relevance of 3q amplification in squamous cell carcinoma of the lung

Fawzi Abu Rous, Pin Li, Shannon L. Carskadon…·Nallasivam Palanisamy

This study identifies a 25-gene minimal common region on 3q amplified in 44% of LUSC cases, associated with improved disease-specific survival and progression-free interval.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky